Evidence map›Paper›PMID 35414059›Full record

ArticleNature communications2022

Author Correction: Investigation of Cas9 antibodies in the human eye.

Marcus A Toral, Carsten T Charlesworth, Benjamin Ng, Teja Chemudupati, Shota Homma, Hiromitsu Nakauchi, Alexander G Bassuk, Matthew H Porteus, Vinit B Mahajan

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Marcus A ToralMolecular Surgery Program, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Carsten T CharlesworthDepartment of Pediatrics, Stanford University, Palo Alto, CA, USA.
Benjamin NgMolecular Surgery Program, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, USA.ORCID http://orcid.org/0000-0003-4296-2948
Teja ChemudupatiMolecular Surgery Program, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Shota HommaDepartment of Genetics, Stanford University, Palo Alto, CA, USA.
Hiromitsu NakauchiDepartment of Genetics, Stanford University, Palo Alto, CA, USA.ORCID http://orcid.org/0000-0002-9841-6973
Alexander G BassukDepartments of Pediatrics and Neurology and The Iowa Neuroscience Institute (INI), University of Iowa, Iowa City, IA, USA.ORCID http://orcid.org/0000-0002-4067-2157
Matthew H PorteusDepartment of Pediatrics, Stanford University, Palo Alto, CA, USA. mporteus@stanford.edu.ORCID http://orcid.org/0000-0002-3850-4648
Vinit B MahajanMolecular Surgery Program, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, USA. vinit.mahajan@stanford.edu.ORCID http://orcid.org/0000-0003-1886-1741
Palo Alto University · USStanford University · USUniversity of Iowa · USCalifornia Institute for Regenerative Medicine · USUniversity of Oxford · GBVA Palo Alto Health Care System · US

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Medical Scientist Training ProgramT32GM139776 · NIGMS · UNIVERSITY OF IOWA · PI Gordon F Buchanan · 2021 to 2026
$6.4M
NEI NIH HHS P30 EY026877NIGMS NIH HHS T32 GM139776
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35414059
PMCPMC9005661
OpenAlexW4223640261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.